Therapeutic angiogenesis using autologous bone marrow mononuclear cells implantation for Buerger disease - Therapeutic angiogenesis using autologous bone marrow mononuclear cells implantation for Buerger disease

Kyoto Prefectural University School of Medicine0 sites25 target enrollmentMay 18, 2017

ConditionsCLI(Critical limb ischemia) (Buerger disease)

Overview

Phase: 未知
Intervention: Not specified
Conditions: CLI(Critical limb ischemia) (Buerger disease)
Sponsor: Kyoto Prefectural University School of Medicine
Enrollment: 25
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

May 18, 2017

End Date

September 30, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Kyoto Prefectural University School of Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Even if the disease and the way type are suitable, or informed consent is not obtained from a patient, it is feelings consideration to a patient family. When I am required and it is difficult to be adapted. 2\. When diagnosed as malignant tumor by inspections. 3\. When it has ischemic cardiopathy and blood circulation reconstruction is not performed. 4\. Serious illness diabetic retinopathy with no treatment. 5\. When it has serious infection. 6\. When critical impaired liver function and renal dysfunction (maintenance dialysis patient removes)exist. 7\. When serious anemia which needs blood dyscrasia and transfusion with white corpuscle reduction,critical decrease of platelets, etc. exists. 8\. Nursing mother when there are under pregnancy and possibility of pregnancy. 9\. Simultaneous with the final examination, or those to the final examination that incorporated and participated in other clinical tests of trial drug or products on the market (medical equipment is included) within 30 days. 10\. When the serious anemia which needs blood dyscrasia and transfusion with white corpuscle reduction, a critical decrease of platelets, etc. exists. 11\. There are other acute and chronic medical serious and mental state, and abnormalities in a clinical laboratory test result. Danger may increase by test participation. The patient who may have on the interpretation of a test result. The patient to whom the examination responsibility (assignment) doctor judged the participation in the final examination to be unsuitable. 12\. In addition, when a family doctor and a medical specialist judge it as a stop.